It is a trading private limited company based in Allahabad, Uttar Pradesh, India, established in 1981.
1981 | Allahabad, Uttar Pradesh, India | ActiveOculus Pharmaceuticals Private Limited, a active private limited company, was established on 05 March 1981 in Allahabad, Uttar Pradesh, India. Engaging in other wholesale within the trade sector, it holds CIN: U24231UP1981PTC005219. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.34 M.
It upholds a compliant status. Its leadership includes Alok Kumar Singh (Director), Krishan Babu Srivastva (Director), Meenakshi Singh (Director). Past directors included Guru Prasad Khare. Its latest AGM occurred on 14 September 2024, with the balance sheet filed on 31 March 2024. It is based at 276/2, Luker Ganj, Prayagraj, Allahabad, Uttar Pradesh, 211001.
U24231UP1981PTC005219
005219
05 March 1981
₹1.50 M
₹1.34 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Oculus Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Alok Kumar Singh | Director | 22 Feb 2010 | Current |
| Krishan Babu Srivastva | Director | 22 Feb 2010 | Current |
| Meenakshi Singh | Director | 22 Feb 2010 | Current |
| Shakuntala Srivastava | Director | 21 Oct 2024 | Current |
| Ram Bhawan Ram | Director | 05 Mar 1981 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 22 Jul 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Oculus Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Oculus Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Oculus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Oculus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oculus Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Shakuntala Srivastava was appointed as a Director was appointed as a Director on 21 Oct 2024 & has been associated with this company since 1 year 1 month . was documented.
Oculus Pharmaceuticals Private Limited last Annual general meeting of members was held on 14 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Oculus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was documented.
Alok Kumar Singh was appointed as a Director was appointed as a Director on 22 Feb 2010 & has been associated with this company since 15 years 9 months . was recorded as a recent event.
Krishan Babu Srivastva was appointed as a Director was appointed as a Director on 22 Feb 2010 & has been associated with this company since 15 years 9 months . was recorded as a recent event.
The activity Meenakshi Singh was appointed as a Director was appointed as a Director on 22 Feb 2010 & has been associated with this company since 15 years 9 months . was completed.
The CIN of Oculus Pharmaceuticals Private Limited is U24231UP1981PTC005219.
Oculus Pharmaceuticals Private Limited is headquartered at 276/2, Luker Ganj, Prayagraj, Allahabad, Uttar Pradesh, 211001.
Oculus Pharmaceuticals Private Limited was incorporated on 05 March 1981.
The current directors of Oculus Pharmaceuticals Private Limited are
The primary industry of Oculus Pharmaceuticals Private Limited is Trade.
Oculus Pharmaceuticals Private Limited is unlisted.
The authorized capital of Oculus Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹1.34 M.
The compliance status of Oculus Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX